1. Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. Issue 2 (16th September 2020) Authors: Ataca Atilla, Pinar; McKenna, Mary K; Tashiro, Haruko; Srinivasan, Madhuwanti; Mo, Feiyan; Watanabe, Norihiro; Simons, Brian Wesley; McLean Stevens, Alexandra; Redell, Michele S; Heslop, Helen E; Mamonkin, Maksim; Brenner, Malcolm K; Atilla, Erden Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. Issue 2 (16th September 2020) Authors: Ataca Atilla, Pinar; McKenna, Mary K; Tashiro, Haruko; Srinivasan, Madhuwanti; Mo, Feiyan; Watanabe, Norihiro; Simons, Brian Wesley; McLean Stevens, Alexandra; Redell, Michele S; Heslop, Helen E; Mamonkin, Maksim; Brenner, Malcolm K; Atilla, Erden Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. Issue 2 (16th September 2020) Authors: Ataca Atilla, Pinar; McKenna, Mary K; Tashiro, Haruko; Srinivasan, Madhuwanti; Mo, Feiyan; Watanabe, Norihiro; Simons, Brian Wesley; McLean Stevens, Alexandra; Redell, Michele S; Heslop, Helen E; Mamonkin, Maksim; Brenner, Malcolm K; Atilla, Erden Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. Issue 2 (16th September 2020) Authors: Ataca Atilla, Pinar; McKenna, Mary K; Tashiro, Haruko; Srinivasan, Madhuwanti; Mo, Feiyan; Watanabe, Norihiro; Simons, Brian Wesley; McLean Stevens, Alexandra; Redell, Michele S; Heslop, Helen E; Mamonkin, Maksim; Brenner, Malcolm K; Atilla, Erden Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. Issue 2 (16th September 2020) Authors: Ataca Atilla, Pinar; McKenna, Mary K; Tashiro, Haruko; Srinivasan, Madhuwanti; Mo, Feiyan; Watanabe, Norihiro; Simons, Brian Wesley; McLean Stevens, Alexandra; Redell, Michele S; Heslop, Helen E; Mamonkin, Maksim; Brenner, Malcolm K; Atilla, Erden Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. Issue 2 (16th September 2020) Authors: Ataca Atilla, Pinar; McKenna, Mary K; Tashiro, Haruko; Srinivasan, Madhuwanti; Mo, Feiyan; Watanabe, Norihiro; Simons, Brian Wesley; McLean Stevens, Alexandra; Redell, Michele S; Heslop, Helen E; Mamonkin, Maksim; Brenner, Malcolm K; Atilla, Erden Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. Issue 2 (16th September 2020) Authors: Ataca Atilla, Pinar; McKenna, Mary K; Tashiro, Haruko; Srinivasan, Madhuwanti; Mo, Feiyan; Watanabe, Norihiro; Simons, Brian Wesley; McLean Stevens, Alexandra; Redell, Michele S; Heslop, Helen E; Mamonkin, Maksim; Brenner, Malcolm K; Atilla, Erden Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. Issue 2 (16th September 2020) Authors: Ataca Atilla, Pinar; McKenna, Mary K; Tashiro, Haruko; Srinivasan, Madhuwanti; Mo, Feiyan; Watanabe, Norihiro; Simons, Brian Wesley; McLean Stevens, Alexandra; Redell, Michele S; Heslop, Helen E; Mamonkin, Maksim; Brenner, Malcolm K; Atilla, Erden Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. Issue 2 (16th September 2020) Authors: Ataca Atilla, Pinar; McKenna, Mary K; Tashiro, Haruko; Srinivasan, Madhuwanti; Mo, Feiyan; Watanabe, Norihiro; Simons, Brian Wesley; McLean Stevens, Alexandra; Redell, Michele S; Heslop, Helen E; Mamonkin, Maksim; Brenner, Malcolm K; Atilla, Erden Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗